Compare Avantis International Small Cap Value ETF (AVDV) vs Cassava Sciences Inc (FLNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Avantis International Small Cap Value ETF vs Cassava Sciences Inc — how do they compare? Avantis International Small Cap Value ETF trades at $109.58, while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: Avantis International Small Cap Value ETF is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| AVDV | FLNA | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $110.40 | $4.64 |
52-Week Low | $83.89 | $0.87 |
Market Cap | — | $47.75M |
Enterprise Value | — | -$34.93M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AVDV trades at $109.63, up 1.34% on the day, with a bullish technical signal from moving averages but caution from oscillators like the RSI. The stock has delivered strong returns recently, including a 35% gain highlighted in June 2026 news, and offers a dividend with a payment scheduled for June 2026. However, key valuation ratios such as P/E and P/B are unavailable, limiting fundamental clarity.
The outlook is mixed: technical strength and positive media coverage on international small-cap value performance support upside, but overbought RSI levels and missing financial metrics pose risks. Investors should weigh the ETF's exposure to developed markets outside the U.S. against potential volatility from commodity sectors, as noted in recent analysis.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Avantis International Small Cap Value ETF
AVDV is an actively managed ETF that targets small-cap value companies in developed markets outside the United States. It uses a systematic, rules-based process to identify firms trading at low valuations with high profitability, aiming to capture the 'size' and 'value' premiums while maintaining broad diversification.
Read more on AVDV →About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →
